Abstract
SO-27 Modified FOLFOXIRI plus cetuximab and avelumab as initial therapy in RAS wild-type unresectable metastatic colorectal cancer: Results of the phase II AVETRIC trial by GONO
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have